How can we tell when cancer vaccines vaccinate?

被引：7

作者：

Wolchok, JD ^{[1
]}

Chapman, PB ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 04期

关键词：

D O I：

10.1200/JCO.2003.12.065

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：586 / 587

页数：2

共 5 条

[1] Phenotypic analysis of antigen-specific T lymphocytes [J].

Altman, JD ;

Moss, PAH ;

Goulder, PJR ;

Barouch, DH ;

McHeyzerWilliams, MG ;

Bell, JI ;

McMichael, AJ ;

Davis, MM .

SCIENCE, 1996, 274 (5284) :94-96

[2]

BERD D, 1986, CANCER RES, V46, P2572

[3] ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction [J].

Hodi, FS ;

Schmollinger, JC ;

Soiffer, RJ ;

Salgia, R ;

Lynch, T ;

Ritz, J ;

Alyea, EP ;

Yang, JH ;

Neuberg, D ;

Mihm, M ;

Dranoff, G .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6919-6924

[4] High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of Intergroup trial E1694/S9512/C509801 [J].

Kirkwood, JM ;

Ibrahim, JG ;

Sosman, JA ;

Sondak, VK ;

Agarwala, SS ;

Ernstoff, MS ;

Rao, U .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) :2370-2380

[5] Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma [J].

Salgia, R ;

Lynch, T ;

Skarin, A ;

Lucca, J ;

Lynch, C ;

Jung, K ;

Hodi, FS ;

Jaklitsck, M ;

Mentzer, S ;

Swanson, S ;

Lukanich, J ;

Buena, R ;

Wain, J ;

Mathisen, D ;

Wright, C ;

Fidias, P ;

Donahue, D ;

Clift, S ;

Hardy, S ;

Neuberg, D ;

Mulligan, R ;

Webb, I ;

Sugarbaker, D ;

Mihm, M ;

Dranoff, G .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) :624-630

← 1 →